As a starting point to evaluate the potential benefit of anti-syntenin drugs, we here aimed to document and compare the impact of syntenin loss-of-function on the migration, invasion, growth, and proliferation of various model cancer cell lines. This evidence concerns the gene SDCBP and cancer.